Answers are grounded in this paper and cite their sources.
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
No takes yet. Share an insight, caveat, or question.
Krystal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: